CDC’s Diagnostic Multiplex Assay for Flu and COVID-19 and Supplies

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Dec. 16, 2020
  
  The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection.
  
  As of December 16, 2020
  
  • Added information on CDC amendment granted by FDA on November 20, 2020
  
  How Public Health Laboratories Order the Flu SC2 Multiplex Assay -- Materials included in the assay -- Other materials labs need to perform the assay -- More Resources for the Flu SC2 Multiplex Assay -- Fact Sheets for the Flu SC2 Multiplex Assay -- More Resources for Diagnostic Testing for COVID-19 and Flu.
  
  
• Subjects:
  Betacoronavirus Clinical Laboratory Techniques Coronavirus Infections/diagnosis COVID-19 Testing Diagnostic Tests, Routine Laboratories Pneumonia, Viral/diagnosis Reagent Kits, Diagnostic Real-Time Polymerase Chain Reaction Serologic Tests
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:5be9589d6a2da833efce09018993f8e2386fa35976acf6c4e4ca4d408f1696575a8a94d073fa672d189a28c1f2fcab68498cc79719767bce641dad097ccf0c84
• Download URL:
  https://stacks.cdc.gov/view/cdc/98857/cdc_98857_DS1.pdf
• File Type:
  [PDF - 115.25 KB ]